Literature DB >> 25359197

Risk factors of recipient site infection in head and neck cancer patients undergoing pectoralis major myocutaneous flap reconstruction.

Chao-Hsien Wang1, Yong-Kie Wong2, Ching-Ping Wang1, Chen-Chi Wang1, Rong-San Jiang1, Chih-Sheng Lai3, Shih-An Liu4,5.   

Abstract

The aim of this study was to investigate the factors associated with infection at the recipient site of pectoralis major myocutaneous flap (PMMF) of head and neck cancer patients. We retrospectively reviewed head and neck cancer patients who underwent PMMF reconstruction and identified those with recipient site infection. Variables of patients with and without infection were compared and associated factors were investigated by logistic regression model. A total of 478 patients were included in the final analysis and 183 patients (38.3%) developed recipient site infection. Lower margin of skin island, concurrent tracheotomy, diabetes mellitus, mandibular plate reconstruction, prior radiation, and peri-operative blood transfusion were independent factors associated with recipient site infection of PMMF. Skin island of PMMF beyond the eighth intercostal space markedly increased the risk of recipient site infection after major head and neck cancer surgery. Recognition of relevant factors associated with infection may help surgeons to identify those at risk.

Entities:  

Keywords:  Head neck cancer; Logistic regression model; Pectoralis major myocutaneous flap; Radiation; Surgical site infection

Mesh:

Year:  2014        PMID: 25359197     DOI: 10.1007/s00405-014-3372-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  18 in total

1.  Three-dimensional anatomical vascular distribution in the pectoralis major myocutaneous flap.

Authors:  Hideaki Rikimaru; Kensuke Kiyokawa; Youjirou Inoue; Yoshiaki Tai
Journal:  Plast Reconstr Surg       Date:  2005-04-15       Impact factor: 4.730

2.  Comparison between free flap and pectoralis major pedicled flap for reconstruction in oral cavity cancer patients--a quality of life analysis.

Authors:  Chih-Yu Hsing; Yong-Kie Wong; Ching Ping Wang; Chen-Chi Wang; Rong-San Jiang; Fun-Jou Chen; Shih-An Liu
Journal:  Oral Oncol       Date:  2011-04-17       Impact factor: 5.337

3.  Complications of the pectoralis major myocutaneous flap in head and neck reconstruction.

Authors:  J P Shah; V Haribhakti; T R Loree; P Sutaria
Journal:  Am J Surg       Date:  1990-10       Impact factor: 2.565

4.  Indications for pedicled pectoralis major flap in a free tissue transfer practice.

Authors:  Daniel S Schneider; Vivian Wu; Mark K Wax
Journal:  Head Neck       Date:  2011-11-15       Impact factor: 3.147

5.  Risk factors of surgical site infection in patients undergoing major oncological surgery for head and neck cancer.

Authors:  Dong Hwan Lee; Sang Yoon Kim; Soon Yuhl Nam; Seung-Ho Choi; Jong Woo Choi; Jong-Lyel Roh
Journal:  Oral Oncol       Date:  2011-05-04       Impact factor: 5.337

Review 6.  Pectoralis major myocutaneous pedicled flap in head and neck reconstruction: retrospective review of indications and results in 244 consecutive cases at the Toronto General Hospital.

Authors:  R Liu; P Gullane; D Brown; J Irish
Journal:  J Otolaryngol       Date:  2001-02

7.  The pectoralis major flap in head and neck reconstruction: first 500 patients.

Authors:  Aleksandar Milenović; Miso Virag; Vedran Uglesić; Naranda Aljinović-Ratković
Journal:  J Craniomaxillofac Surg       Date:  2006-07-24       Impact factor: 2.078

8.  Pectoralis major and other myofascial/myocutaneous flaps in head and neck cancer reconstruction: experience with 437 cases at a single institution.

Authors:  José Guilherme Vartanian; André Lopes Carvalho; Solange Maria T Carvalho; Lia Mizobe; José Magrin; Luiz Paulo Kowalski
Journal:  Head Neck       Date:  2004-12       Impact factor: 3.147

9.  Antimicrobial prophylaxis for contaminated head and neck surgery.

Authors:  J T Johnson; E N Myers; P B Thearle; B A Sigler; V L Schramm
Journal:  Laryngoscope       Date:  1984-01       Impact factor: 3.325

10.  Pectoralis major myocutaneous flap vs revascularized free tissue transfer: complications, gastrostomy tube dependence, and hospitalization.

Authors:  Douglas B Chepeha; Gail Annich; Melissa A Pynnonen; Jill Beck; Gregory T Wolf; Theodoros N Teknos; Carol R Bradford; William R Carroll; Ramon M Esclamado
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02
View more
  6 in total

1.  Factors contributing to surgical site infection in patients with oral cancer undergoing microvascular free flap reconstruction.

Authors:  Sheng-Chiao Lin; Ting-Shou Chang; Kuo-Chung Yang; Yaoh-Shiang Lin; Yu-Hsuan Lin
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-09       Impact factor: 2.503

Review 2.  Association between blood transfusions and complications in head and neck reconstruction: a systematic review and meta-analysis.

Authors:  Francesco Giovacchini; Caterina Bensi; Daniele Paradiso; Raffaella Docimo; Antonio Tullio
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-01       Impact factor: 2.503

3.  Reliability of the pectoralis major myocutaneous flap in reconstructive oral cancer surgery in developing countries: Our experience.

Authors:  Atanu Bhanja; D S J D'Souza; Collin Roy; R N Poddar
Journal:  Med J Armed Forces India       Date:  2016-05-04

4.  The application of temporo-occipital fascial flap in the wound of medium scalp defect with bone exposure.

Authors:  Jian-Li Wang; Wen-Gang Huang; Xing-Long Liu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

5.  Pectoralis major myocutaneous flap in salvage reconstruction following free flap failure in head and neck cancer surgery.

Authors:  Wei Wei; Yongsheng Qiu; Qigen Fang; Yingping Jia
Journal:  J Int Med Res       Date:  2018-12-05       Impact factor: 1.671

6.  Post-Operative Infections in Head and Neck Cancer Surgery: Risk Factors for Different Infection Sites.

Authors:  Giancarlo Pecorari; Giuseppe Riva; Andrea Albera; Ester Cravero; Elisabetta Fassone; Andrea Canale; Roberto Albera
Journal:  J Clin Med       Date:  2022-08-24       Impact factor: 4.964

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.